Fertility Drug and Surgery Market 2019

1. Fertility Drug and Surgery Market Expend the Global Share at 9.8% CAGR with Rise in Infertility Diseases and Obesity | Latest MRFR Brief 2019 Market Research Future (MRFR) has highlighted in its latest analysis that the global fertility drug and surgery market is projected to expand at a CAGR of 9.8% during the projection period of 2018 to 2023. Market Overview: The rates of infertility are getting higher, which has encouraged massive investments in the research & development of effective drugs and surgeries. Infertility diseases affect both men and women. Treatments have been developed for both the genders and drug research is expected to constantly drive the expansion of the fertility drug and surgery market over the next couple of years. In addition, rising working population of women has led to increased cases of late pregnancies. This, in turn, is prognosticated to boost the revenue creation of the fertility drug and surgery market over the next couple of years. Request the FREE Sample@ https://www.marketresearchfuture.com/sample_request/7588 Obesity is also a significant factor driving the growth of the market. Increasing burden of obesity has led to an exponential increase in the prevalence of infertility. It is projected to catapult the global fertility drug and surgery market on an upward trajectory over the forecast period. Other factors such as increasing disposable income, rising healthcare expenditure, etc. are poised to influence the market positively. However, on the flip side, factors such as high treatment cost and complications associated with surgeries is anticipated to restrict market growth over the next few years. Market Segmentation: Based on the underlying cause, the global fertility drug and surgery market has been segmented into male and female. By drug, the fertility drug and surgery market has been segmented into letrozole, Serophene, clomiphene citrate, hormone treatment, gonadotrophins estrogen receptor modulators, aromatase inhibitors, dopamine agonists, metformin hydrochloride, and others. Depending on the procedures, the global fertility drug and surgery market has been segmented into laparoscopy and robotic laparoscopy, hysteroscopy, laparotomy/open surgery, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), egg retrieval, sperm retrieval (epididymal aspiration). Based on end-user, the fertility drug and surgery market has been segmented into hospitals, clinical research institutes, fertility clinics, and others. Global Fertility Drug and Surgery Market, by Key Players Eli Lilly Market Research Future

2. Baxter Healthcare Corporation Ferring Pharmaceuticals, Inc. Merck & Co. Pharmaceutical Company Noven Pharmaceuticalorganon, Inc. Janssen Pharmaceuticals Inc. Personal Products Company Pfizer, Inc. Procter & Gamble Pharmaceuticals Emd Serono, Inc. Get Full Detailed Copy of This Report@ https://www.marketresearchfuture.com/reports/fertility-drug- surgery-market-7588 Regional Analysis: A detailed geographical analysis of the global fertility drug and surgery market has been included in this MRFR report which covers four major regions – Americas, Asia Pacific, Europe, and the Middle East & Africa (MEA). Americas is likely to lead the expansion of the market on account of the increasing rate of infertility in the region. Rising prevalence of obesity and increasing cases of delayed pregnancies are anticipated to catapult the global fertility drug and surgery market on upward trajectory in the years to come. Europe held the second leading position in 2017. It has been studied in this report that the riding prevalence of sexually transmitted diseases is responsible for increasing infertility rate in the region. On the other hand, Asia Pacific fertility drug and surgery market is poised to exhibit immense developments. Factors such as rising awareness, availability of healthcare services, etc. are projected to boost revenue growth of the fertility drug and surgery market in the region over the next few years. LIST OF TABLES TABLE 1 GLOBAL FERTILITY DRUG AND SURGERY MARKET SYNOPSIS, 2018–2023 TABLE 2 GLOBAL FERTILITY DRUG AND SURGERY MARKET ESTIMATES AND FORECAST, 2018–2023 (USD MILLION) TABLE 3 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2018–2023 (USD MILLION) TABLE 4 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2018–2023 (USD MILLION) TABLE 5 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2018–2023 (USD MILLION) TABLE 6 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2018–2023 (USD MILLION) TABLE 7 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2018–2023(USD MILLION) Market Research Future

3. TABLE 8 NORTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2018–2023 (USD MILLION) …To be Continued. Ask for an Amazing Discount@ https://www.marketresearchfuture.com/check-discount/7588 Few of these strategies are mergers & acquisitions, collaborations, partnerships, etc. Investments are also anticipated to be injected in the future trajectory of the fertility drug and surgery market for gaining edge over competitors. About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future